(Q33656455)

28 July 2017

title

Lipid-based amphotericin B formulations: from animals to man. (English)

1 reference

28 July 2017

1 reference

Bekersky I I

1

1 reference

28 July 2017

Fielding RM

series ordinal

2

1 reference

28 July 2017

Buell D

series ordinal

3

1 reference

28 July 2017

Lawrence I I

series ordinal

4

1 reference

28 July 2017

publication date

1 June 1999

1 reference

Pharmaceutical science & technology today

28 July 2017

published in

1 reference

28 July 2017

volume

2

1 reference

28 July 2017

issue

6

1 reference

28 July 2017

page(s)

230-236

1 reference

The emergence of fungi as major hospital pathogens

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

New spectrum of fungal infections in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Amphotericin B. Still the 'gold standard' for antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Fungal Sterols and the Mode of Action of the Polyene Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Treatment of systemic fungal infections: recent progress and current problems

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Disintegration of phosphatidylcholine liposomes in plasma as a result of interaction with high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

In vivo evaluation of the effect of the size and opsonization on the hepatic extraction of liposomes in rats: an application of Oldendorf method

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Antileishmanial activity of amphotericin and other antifungal agents entrapped in liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Liposome-encapsulated amphotericin B for treatment of disseminated candidiasis in neutropenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Unusual lipid structures selectively reduce the toxicity of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Lipid formulations of amphotericin B: recent progress and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Lipid formulations of amphotericin B: clinical efficacy and toxicities

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and Fungizone after repeated dosing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Single-dose pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin B administered to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Phase I study of amphotericin B colloidal dispersion for the treatment of invasive fungal infections after marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Treatment of invasive fungal infections in renally impaired patients with amphotericin B colloidal dispersion

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

AmBisome (liposomal amphotericin B): a comparative review.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Effect of variation in infrrsion time and macrophage blockade on organ uptake of amphotericin B-deoxycholate

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Phagocyte transport as mechanism for enhanced therapeutic activity of liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Comparison of fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in the treatment of experimental murine aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1461-5347%2899%2900160-1

7 January 2021

10.1016/S1461-5347(99)00160-1

Identifiers

DOI

1 reference

28 July 2017

1 reference